{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:05:38Z","timestamp":1793160338147,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ijid.2020.09.019","type":"journal-article","created":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T01:41:36Z","timestamp":1599961296000},"page":"24-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance"],"prefix":"10.1016","volume":"101","author":[{"given":"Francesca","family":"Gioia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Gomez-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Gomez-Garc\u00eda de la Pedrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Mart\u00edn-Davila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Cuenca-Estrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Fortun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2020.09.019_bib0005","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1093\/jac\/dkt542","article-title":"Anidulafungin dosing in critically ill patients with continuous venovenous haemodiafiltration","volume":"69","author":"Aguilar","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2020.09.019_bib0010","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/cc13805","article-title":"Pharmacokinetics of anidulafungin during albumin dialysis","volume":"1","author":"Aguilar","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.ijid.2020.09.019_bib0015","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1128\/AAC.01584-09","article-title":"In vivo comparison of the pharmacodynamic target among echinocandin drugs and Candida species","volume":"54","author":"Andes","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.ijid.2020.09.019_bib0020","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1128\/AAC.01430-10","article-title":"Use of pharmacokinetic-pharmacodynamic analyses to optimize therapy with the systemic antifungal micafungin for invasive candidiasis or candidemia","volume":"55","author":"Andes","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2020.09.019_bib0025","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s00134-013-3109-3","article-title":"A research agenda on the management of intraabdominal candidiasis: results from a consensus of multinational experts","volume":"39","author":"Bassetti","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijid.2020.09.019_bib0030","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1128\/AAC.02189-13","article-title":"Breakthrough candidemia due to multidrug resistant Candida glabrata during prophylaxis with a low dose of micafungin","volume":"58","author":"Bizerra","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2020.09.019_bib0035","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01542-16","article-title":"In vitro exposure to increasing micafungin concentrations easily promotes echinocandin resistance in Candida glabrata isolates","volume":"61","author":"Bordallo-Cardona","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2020.09.019_bib0040","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/mmy\/myx124","article-title":"Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata","volume":"56","author":"Bordallo-Cardona","year":"2018","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijid.2020.09.019_bib0045","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01982-17","article-title":"Mutant prevention concentration and mutant selection window of micafungin and anidulafungin in clinical Candida glabrata isolates","volume":"62","author":"Bordallo-Cardona","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.ijid.2020.09.019_bib0050","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/AAC.00323-13","article-title":"Determination of voriconazole serum concentration by bioassay, a valid method for therapeutic drug monitoring for clinical laboratories","volume":"57","author":"Cendejas-Bueno","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2020.09.019_bib0055","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/jac\/dkx047","article-title":"Changing epidemiology of candidaemia in Australia","volume":"72","author":"Chapman","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2020.09.019_bib0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2020.09.019_bib0065","first-page":"1429","article-title":"Pharmacokinetic study of anidulafungin in ICU patients with intraabdominal candidiasis","volume":"72","author":"Dupont","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.ijid.2020.09.019_bib0070","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/mmy\/myz123","article-title":"Roles of the multiplex real-time PCR assay and \u03b2-D-glucan in a high-risk population for intra-abdominal candidiasis (IAC)","volume":"58","author":"Fort\u00fan","year":"2020","journal-title":"Med Mycol"},{"issue":"10","key":"10.1016\/j.ijid.2020.09.019_bib0075","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1093\/jac\/dkv173","article-title":"Plasma and peritoneal fluid population pharmacokinetics of micafungin in post-surgical patients with severe peritonitis","volume":"70","author":"Grau","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2020.09.019_bib0080","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1128\/AAC.02155-13","article-title":"Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011","volume":"58","author":"Guinea","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2020.09.019_bib0085","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1128\/AAC.01490-12","article-title":"Weight drives caspofungin pharmacokinetic variability in overweight and obese people: fractal power signatures beyond two-thirds or three-fourths","volume":"57","author":"Hall","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2020.09.019_bib0090","first-page":"e1412","article-title":"The gastrointestinal tract is a major source of echinocandin drug resistance in a murine model of Candida glabrata colonization and systemic dissemination","volume":"61","author":"Healey","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2020.09.019_bib0095","article-title":"Molecular epidemiology and antifungal susceptibility of Candida glabrata in China (August 2009 to July 2014): a multi-center study","volume":"23","author":"Hou","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijid.2020.09.019_bib0100","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1128\/AAC.01763-15","article-title":"Posttreatment antifungal resistance among colonizing candida isolates in candidemia patients: results from a systematic multicenter study","volume":"60","author":"Jensen","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.ijid.2020.09.019_bib0105","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00378-19","article-title":"Population pharmacokinetics of anidulafungin in critically ill patients","volume":"63","author":"Luque","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2020.09.019_bib0110","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijid.2019.07.008","article-title":"Pharmacokinetics of anidulafungin in critically ill patients with Candida peritonitis","volume":"86","author":"P\u00e9rez Civantos","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2020.09.019_bib0115","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3389\/fmicb.2019.01585","article-title":"Clinical and laboratory development of echinocandin resistance in Candida glabrata: molecular characterization","volume":"10","author":"Rivero-Menendez","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijid.2020.09.019_bib0120","article-title":"Rapid emergence of FKS mutations in Candida glabrata isolates in a peritoneal candidiasis","author":"Sasso","year":"2017","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijid.2020.09.019_bib0125","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s10096-019-03617-9","article-title":"Evaluation of anidulafungin in the treatment of intra-abdominal candidiasis: a pooled analysis of patient-level data from 5 prospective studies","volume":"38","author":"Sganga","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2020.09.019_bib0130","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1128\/AAC.00027-12","article-title":"The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata","volume":"56","author":"Shields","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2020.09.019_bib0135","doi-asserted-by":"crossref","first-page":"7601","DOI":"10.1128\/AAC.04134-14","article-title":"Abdominal candidiasis is a hidden reservoir of echinocandin resistance","volume":"58","author":"Shields","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2020.09.019_bib0140","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01692-18","article-title":"Spontaneous mutational frequency and FKS mutation rates vary by echinocandin agent against Candida glabrata","volume":"63","author":"Shields","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2020.09.019_bib0145","series-title":"Breakpoint Tables for Interpretation of MICs for Antifungal Agents, Version 10.0","author":"The European Committee on Antimicrobial Susceptibility Testing","year":"2020"},{"key":"10.1016\/j.ijid.2020.09.019_bib0150","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00063-18","article-title":"Pharmacokinetics of anidulafungin in obese and normal weight adults","volume":"62","author":"Wasmann","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2020.09.019_bib0155","first-page":"62","article-title":"Anidulafungin pharmacokinetics in ascites fluid and pleural effusion of critically ill patients","author":"Welte","year":"2018","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220307347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220307347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:52:36Z","timestamp":1761119556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971220307347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":31,"alternative-id":["S1201971220307347"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.09.019","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}